[2,9'-Bianthracene]-4',8(1'H,5H)-dione,2',3',6,7-tetrahydro-1,2',5',6,9,10'-hexahydroxy-2',6-dimethyl-, (2S,2'S,6S)- (110270-61-6)

Identification
Name:	[2,9'-Bianthracene]-4',8(1'H,5H)-dione,2',3',6,7-tetrahydro-1,2',5',6,9,10'-hexahydroxy-2',6-dimethyl-, (2S,2'S,6S)-
Synonyms:	PeroxisomicinA1; Peroxisomicine A1; T 514; T 514 (antitumor agent); Toxin T 514
CAS:	110270-61-6
Molecular Formula:	C₃₀H₂₆O₈
Molecular Weight:	0
InChI:	InChI=1/C30H26O8/c1-29(37)9-14-8-13-6-7-16(26(34)22(13)27(35)21(14)19(32)11-29)23-15-4-3-5-18(31)24(15)28(36)25-17(23)10-30(2,38)12-20(25)33/h3-8,31,34-38H,9-12H2,1-2H3
Molecular Structure:
Properties
Flash Point:	467.3°C
Boiling Point:	826.1°C at 760 mmHg
Density:	1.539g/cm³
Refractive index:	1.78
Flash Point:	467.3°C
Safety Data

Other Product

[2,9'-Bianthracene]-4',8(1'H,5H)-dione,2',3',6,7-tetrahydro-1,2',5',6,9,10'-hexahydroxy-3,7'-dimethoxy-2',6-dimethyl-,(2S,2'S,6S)- (9CI)
[2,9'-Bianthracene]-4',8(1'H,5H)-dione,2',3',6,7-tetrahydro-1,2',5',6,9,10'-hexahydroxy-3,7'-dimethoxy-2',6-dimethyl-,(2R,2'S,6S)- (9CI)
[2,9'-Bianthracene]-4',8(1'H,5H)-dione,2',3',6,7-tetrahydro-1,2',5',6,9,10'-hexahydroxy-2',6-dimethyl-, (2S,2'S,6R)-(9CI)
[2,9'-Bianthracene]-4',8(1'H,5H)-dione,2',3',6,7-tetrahydro-1,2',5',6,9,10'-hexahydroxy-3,7'-dimethoxy-2',6-dimethyl-,(2R,2'R,6R)- (9CI)
2',3',6,7-Tetrahydro-1,2',5',6,9,10'-hexahydroxy-3,7'-dimethoxy-2',6-dimethyl-2,9'-bianthracene-4',8(1'H,5H)-dione
[2,9'-Bianthracene]-9,10'(9'H,10H)-dione,1,4',5',8,9',10-hexahydroxy-2',6-dimethyl-10-b-D-xylopyranosyl-
[2,9'-Bianthracene]-9,10'(9'H,10H)-dione,10-b-D-glucopyranosyl-1,4',5',8,9',10-hexahydroxy-2',6-dimethyl-(9CI)
[2,9'-Bianthracene]-8,10'(5H,9'H)-dione,6,7-dihydro-4',5',6-trihydroxy-2',6-dimethyl-
2',3'-Dihydro-1,2',5',8,10'-pentahydroxy-3,7'-dimethoxy-2',6-dimethyl[2,9'-bianthracene]-4',9(1'H,10H)-dione
6,7-Dihydro-1,4',5',6,9-pentahydroxy-2',6-dimethyl[2,9'-bianthracene]-8,10'(5H,9'H)-dione
[1,2'-Bianthracene]-5,8'(5'H,6H)-dione,6',7,7',8-tetrahydro-1',4,6',7,9',10-hexahydroxy-2,3'-dimethoxy-6',7-dimethyl-,(1R,6'S,7S)- (9CI)
[1,2'-Bianthracene]-5,8'(5'H,6H)-dione,6',7,7',8-tetrahydro-1',4,6',7,9',10-hexahydroxy-2,3'-dimethoxy-6',7-dimethyl-(9CI)
Spiro[furan-2(5H),2'(1'H)-naphtho[2,1-b]furan]-5-one,3'a,4',5',5'a,6',7',8',9',9'a,9'b-decahydro-3,3'a,6',6',9'a-pentamethyl-,(2S,3'aR,5'aS,9'aS,9'bR)-
[9,9'-Bianthracene]-4,4'(1H,1'H)-dione,2,2',3,3'-tetrahydro-2,2',5,5',10,10'-hexahydroxy-7,7'-dimethoxy-2,2',6-trimethyl-,(2S,2'S,10S)- (9CI)
Spiro[cyclohexane-1,4'(3'H)-[1H-7,9a]methanocyclohepta[c]pyran]-1',9'(4'aH)-dione,6-(acetyloxy)-2-[(acetyloxy)methyl]tetrahydro-5'-hydroxy-3,3-dimethyl-8'-methylene-,(1R,2R,4'aS,5'S,6S,7'S,9'aS)-
1/C7H8O3/c1-2-9-7(8)6-4-3-5-10-6/h3-5H,2H2,1H
Dispiro[cyclopropane-1,2'(10'H)-phenanthrene-10',2''-phenanthro[3,4-d][1,3]dioxole]-1',4',6'',9'(3'H,8''H)-tetrone,3',6'-bis(acetyloxy)-4'b,5',6',7',8',8'a,9'',10'',11'',11''a-decahydro-5'',7''-dihydroxy-2,4'b,8',8',8'',8'',11''a-heptamethyl-4''-(1-methylethyl)-,(1'S,2S,2''R,3'R,4'bS,6'S,8'aS)- (9CI)
Dispiro[cyclopropane-1,2'(10'H)-phenanthrene-10',2''-phenanthro[3,4-d][1,3]dioxole]-1',4',6'',9'(3'H,8''H)-tetrone,3',6'-bis(acetyloxy)-4'b,5',6',7',8',8'a,9'',10'',11'',11''a-decahydro-5'',7''-dihydroxy-2,4'b,8',8',8'',8'',11''a-heptamethyl-4''-(1-methylethyl)-,(1'S,2S,2''S,3'R,4'bS,6'S,8'aS)- (9CI)
1/C9H8N2OS/c1-13-9-10-7-5-3-2-4-6(7)8(12)11-9/h2-5H,1H3,(H,10,11,12
Spiro[furan-3(2H),1'(2'H)-phenanthren]-5(4H)- one,2'-[(1R,2S)-2-(acetyloxy)-1-methyl-3- [(2S,4R)-tetrahydro-4-methyl-5-oxo-2- furanyl]propyl]-3',4',4'a,4'b,5',6',7',8',8'a,9',10',- 10'a-dodecahydro-7'-hydroxy-4'b,8',8',10'atetramethyl-,(1'S,2'R,4'aR,4'bR,7'S,8'aR,- 10'aR)-